HK1122797A1 - Derivatives of pyrido - Google Patents

Derivatives of pyrido

Info

Publication number: HK1122797A1
Authority: HK; Hong Kong
Prior art keywords: pyrido; derivatives
Prior art date: 2005-07-01

Application number

HK08113767.6A

Other languages

English (en)

Inventor

Bernard Bourrie

Pierre Casellas

Samir Jegham

Claude Muneaux

Pierre Perreaut

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-01

Filing date

2008-12-18

Publication date

2009-05-29

2008-12-18 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2009-05-29 Publication of HK1122797A1 publication Critical patent/HK1122797A1/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis

HK08113767.6A 2005-07-01 2008-12-18 Derivatives of pyrido HK1122797A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0507032A FR2887882B1 (fr)	2005-07-01	2005-07-01	Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
PCT/FR2006/001518 WO2007003765A1 (fr)	2005-07-01	2006-06-29	DERIVES DE PYRIDO[2,3-d]PYRIMIDINE, LEUR PREPARATION, LEUR APPLICATION EN THERAPEUTIQUE

Publications (1)

Publication Number	Publication Date
HK1122797A1 true HK1122797A1 (en)	2009-05-29

Family

ID=36096420

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK08113767.6A HK1122797A1 (en)	2005-07-01	2008-12-18	Derivatives of pyrido

Country Status (41)

Country	Link
US (2)	US7504406B2 (xx)
EP (2)	EP2020410B1 (xx)
JP (1)	JP4472009B2 (xx)
KR (1)	KR101298344B1 (xx)
CN (2)	CN101213196B (xx)
AR (1)	AR054812A1 (xx)
AT (1)	ATE423119T1 (xx)
AU (1)	AU2006264801B2 (xx)
BR (1)	BRPI0613020A2 (xx)
CA (1)	CA2610794C (xx)
CR (1)	CR9568A (xx)
CY (2)	CY1110457T1 (xx)
DE (1)	DE602006005246D1 (xx)
DK (2)	DK1902054T3 (xx)
DO (1)	DOP2006000145A (xx)
EA (1)	EA014312B1 (xx)
EC (1)	ECSP078011A (xx)
ES (2)	ES2450067T3 (xx)
FR (1)	FR2887882B1 (xx)
HK (1)	HK1122797A1 (xx)
HR (2)	HRP20090236T1 (xx)
IL (1)	IL187900A0 (xx)
JO (1)	JO2550B1 (xx)
MA (1)	MA29561B1 (xx)
ME (1)	ME01813B (xx)
MX (1)	MX2007016239A (xx)
MY (1)	MY143089A (xx)
NO (1)	NO20080418L (xx)
NZ (1)	NZ564072A (xx)
PA (1)	PA8684801A1 (xx)
PE (1)	PE20070139A1 (xx)
PL (2)	PL2020410T3 (xx)
PT (2)	PT2020410E (xx)
RS (2)	RS50781B (xx)
SI (2)	SI1902054T1 (xx)
TN (1)	TNSN07440A1 (xx)
TW (1)	TWI321566B (xx)
UA (1)	UA92021C2 (xx)
UY (1)	UY29645A1 (xx)
WO (1)	WO2007003765A1 (xx)
ZA (1)	ZA200711032B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2873118B1 (fr)	2004-07-15	2007-11-23	Sanofi Synthelabo	Derives de pyrido-pyrimidine, leur application en therapeutique
FR2887882B1 (fr) *	2005-07-01	2007-09-07	Sanofi Aventis Sa	Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2896246B1 (fr)	2006-01-13	2008-08-15	Sanofi Aventis Sa	Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
FR2910813B1 (fr) *	2006-12-28	2009-02-06	Sanofi Aventis Sa	Nouvelle utilisation therapeutique pour le traitement des leucemies
CN102186845B (zh)	2008-10-17	2016-09-07	阿卡制药有限公司	S1p受体调节剂以及它们的用途
AU2009304596A1 (en)	2008-10-17	2010-04-22	Akaal Pharma Pty Ltd	S1P receptors modulators
FR2948568B1 (fr)	2009-07-30	2012-08-24	Sanofi Aventis	Formulation pharmaceutique
CN103204827B (zh) *	2012-01-17	2014-12-03	上海科州药物研发有限公司	作为蛋白激酶抑制剂的苯并噻二唑化合物及其制备方法和用途
EP2638911A1 (en)	2012-03-14	2013-09-18	Sanofi	Novel combinations for treating acute myeloid leukaemia or chronic myeloid leukaemia
CN103833771A (zh) *	2012-11-22	2014-06-04	天津滨江药物研发有限公司	作为蛋白激酶Mek抑制剂的苯并五元杂环化合物及其制备方法和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1171218A (en)	1967-11-09	1969-11-19	Parke Davis & Co	New Heterocyclic Amine Compounds and Methods for their Production
JPH04128276A (ja)	1990-09-19	1992-04-28	Pfizer Pharmaceut Co Ltd	アミノベンゾサルタム誘導体およびその用途
IL115256A0 (en)	1994-11-14	1995-12-31	Warner Lambert Co	6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
MX9702245A (es) *	1994-11-14	1997-06-28	Warner Lambert Co	Seis-aril-pirido(2,3-d)pirimidinas y naftiridinas para inhibir la proliferacion celular mediada por la proteina cinasa tirosina.
IL117923A (en)	1995-05-03	2000-06-01	Warner Lambert Co	Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
US5620981A (en)	1995-05-03	1997-04-15	Warner-Lambert Company	Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
AR030044A1 (es) *	2000-01-25	2003-08-13	Warner Lambert Co	Pirido (2,3-d ) pirimidin-2,7-diaminas inhibidores de quinasas
EE200200506A (et) *	2000-03-06	2004-02-16	Warner-Lambert Company	5-alküülpürido[2,3-d]pürimidiinid kui türosiinkinaasi inhibiitorid
MXPA02011263A (es)	2000-08-04	2003-03-10	Warner Lambert Co	2-(4-piridil)amino-6-dialcoxifenil- pirido(2,3-d) pirimidin-7-onas.
WO2003000011A2 (en) *	2001-06-21	2003-01-03	Ariad Pharmaceuticals, Inc.	Novel pyridopyrimidines and uses thereof
AU2002952453A0 (en) *	2002-11-01	2002-11-21	Novogen Research Pty Ltd	Aminated isoflavonoid derivatives and uses thereof
US20050009849A1 (en)	2003-01-03	2005-01-13	Veach Darren R.	Pyridopyrimidine kinase inhibitors
TW200502236A (en) *	2003-03-28	2005-01-16	Hoffmann La Roche	Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
WO2005105097A2 (en)	2004-04-28	2005-11-10	Gpc Biotech Ag	Pyridopyrimidines for treating inflammatory and other diseases
FR2873118B1 (fr)	2004-07-15	2007-11-23	Sanofi Synthelabo	Derives de pyrido-pyrimidine, leur application en therapeutique
FR2887882B1 (fr) *	2005-07-01	2007-09-07	Sanofi Aventis Sa	Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2896246B1 (fr)	2006-01-13	2008-08-15	Sanofi Aventis Sa	Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
US8338435B2 (en) *	2006-07-20	2012-12-25	Gilead Sciences, Inc.	Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections

2005
- 2005-07-01 FR FR0507032A patent/FR2887882B1/fr not_active Expired - Fee Related
2006
- 2006-06-26 DO DO2006000145A patent/DOP2006000145A/es unknown
- 2006-06-28 PE PE2006000754A patent/PE20070139A1/es not_active Application Discontinuation
- 2006-06-28 JO JO2006197A patent/JO2550B1/en active
- 2006-06-29 BR BRPI0613020-8A patent/BRPI0613020A2/pt not_active IP Right Cessation
- 2006-06-29 RS RSP-2009/0225A patent/RS50781B/sr unknown
- 2006-06-29 CA CA2610794A patent/CA2610794C/fr not_active Expired - Fee Related
- 2006-06-29 ES ES08017944.3T patent/ES2450067T3/es active Active
- 2006-06-29 AU AU2006264801A patent/AU2006264801B2/en not_active Ceased
- 2006-06-29 PT PT80179443T patent/PT2020410E/pt unknown
- 2006-06-29 NZ NZ564072A patent/NZ564072A/en not_active IP Right Cessation
- 2006-06-29 SI SI200630273T patent/SI1902054T1/sl unknown
- 2006-06-29 DK DK06778710T patent/DK1902054T3/da active
- 2006-06-29 CN CN2006800237082A patent/CN101213196B/zh not_active Expired - Fee Related
- 2006-06-29 MX MX2007016239A patent/MX2007016239A/es active IP Right Grant
- 2006-06-29 UA UAA200801216A patent/UA92021C2/ru unknown
- 2006-06-29 PT PT06778710T patent/PT1902054E/pt unknown
- 2006-06-29 KR KR1020077030704A patent/KR101298344B1/ko not_active IP Right Cessation
- 2006-06-29 DK DK08017944.3T patent/DK2020410T3/en active
- 2006-06-29 WO PCT/FR2006/001518 patent/WO2007003765A1/fr active Application Filing
- 2006-06-29 EA EA200800223A patent/EA014312B1/ru not_active IP Right Cessation
- 2006-06-29 ZA ZA200711032A patent/ZA200711032B/xx unknown
- 2006-06-29 CN CN201110187994.9A patent/CN102260258B/zh not_active Expired - Fee Related
- 2006-06-29 JP JP2008518918A patent/JP4472009B2/ja not_active Expired - Fee Related
- 2006-06-29 ME MEP-2014-28A patent/ME01813B/me unknown
- 2006-06-29 EP EP08017944.3A patent/EP2020410B1/fr active Active
- 2006-06-29 AT AT06778710T patent/ATE423119T1/de active
- 2006-06-29 DE DE602006005246T patent/DE602006005246D1/de active Active
- 2006-06-29 PL PL08017944T patent/PL2020410T3/pl unknown
- 2006-06-29 MY MYPI20063117A patent/MY143089A/en unknown
- 2006-06-29 SI SI200631750T patent/SI2020410T1/sl unknown
- 2006-06-29 ES ES06778710T patent/ES2322101T3/es active Active
- 2006-06-29 EP EP06778710A patent/EP1902054B1/fr active Active
- 2006-06-29 RS RS20140121A patent/RS53211B/en unknown
- 2006-06-29 PL PL06778710T patent/PL1902054T3/pl unknown
- 2006-06-30 UY UY29645A patent/UY29645A1/es unknown
- 2006-06-30 AR ARP060102833A patent/AR054812A1/es active IP Right Grant
- 2006-06-30 TW TW095123940A patent/TWI321566B/zh not_active IP Right Cessation
- 2006-06-30 PA PA20068684801A patent/PA8684801A1/es unknown
2007
- 2007-11-26 TN TNP2007000440A patent/TNSN07440A1/en unknown
- 2007-12-04 IL IL187900A patent/IL187900A0/en not_active IP Right Cessation
- 2007-12-06 CR CR9568A patent/CR9568A/es unknown
- 2007-12-13 EC EC2007008011A patent/ECSP078011A/es unknown
- 2007-12-13 US US11/955,583 patent/US7504406B2/en active Active
- 2007-12-24 MA MA30502A patent/MA29561B1/fr unknown
2008
- 2008-01-22 NO NO20080418A patent/NO20080418L/no not_active Application Discontinuation
- 2008-12-18 HK HK08113767.6A patent/HK1122797A1/xx not_active IP Right Cessation
2009
- 2009-01-30 US US12/362,656 patent/US8008310B2/en active Active
- 2009-04-22 HR HR20090236T patent/HRP20090236T1/xx unknown
- 2009-05-11 CY CY20091100498T patent/CY1110457T1/el unknown
2014
- 2014-03-18 HR HRP20140246TT patent/HRP20140246T1/hr unknown
- 2014-03-18 CY CY20141100211T patent/CY1114989T1/el unknown

Also Published As

Publication number	Publication date
DE602006005246D1 (de)	2009-04-02
CR9568A (es)	2008-02-20
MA29561B1 (fr)	2008-06-02
PE20070139A1 (es)	2007-03-07
EA014312B1 (ru)	2010-10-29
AU2006264801B2 (en)	2012-05-10
WO2007003765A1 (fr)	2007-01-11
DK1902054T3 (da)	2009-06-15
JP2008544975A (ja)	2008-12-11
ES2322101T3 (es)	2009-06-16
CY1110457T1 (el)	2015-04-29
ME01813B (me)	2014-09-20
MY143089A (en)	2011-03-15
US20080176874A1 (en)	2008-07-24
DK2020410T3 (en)	2014-03-24
US7504406B2 (en)	2009-03-17
RS50781B (sr)	2010-08-31
ATE423119T1 (de)	2009-03-15
CA2610794A1 (fr)	2007-01-11
CA2610794C (fr)	2012-02-21
MX2007016239A (es)	2008-03-06
EP1902054B1 (fr)	2009-02-18
NO20080418L (no)	2008-03-28
FR2887882A1 (fr)	2007-01-05
AU2006264801A1 (en)	2007-01-11
CN102260258B (zh)	2015-01-07
JP4472009B2 (ja)	2010-06-02
UA92021C2 (ru)	2010-09-27
EP2020410A1 (fr)	2009-02-04
HRP20090236T1 (en)	2009-05-31
ES2450067T3 (es)	2014-03-21
EP2020410B1 (fr)	2013-12-18
SI1902054T1 (sl)	2009-06-30
IL187900A0 (en)	2008-03-20
HRP20140246T1 (hr)	2014-06-20
PL2020410T3 (pl)	2014-05-30
KR101298344B1 (ko)	2013-08-20
AR054812A1 (es)	2007-07-18
KR20080021714A (ko)	2008-03-07
PL1902054T3 (pl)	2009-07-31
TNSN07440A1 (en)	2009-03-17
NZ564072A (en)	2012-02-24
ZA200711032B (en)	2009-04-29
UY29645A1 (es)	2007-01-31
CN102260258A (zh)	2011-11-30
US8008310B2 (en)	2011-08-30
CN101213196B (zh)	2011-09-07
TW200745102A (en)	2007-12-16
EP1902054A1 (fr)	2008-03-26
US20090163522A1 (en)	2009-06-25
EA200800223A1 (ru)	2008-06-30
ECSP078011A (es)	2008-01-23
PA8684801A1 (es)	2007-01-17
FR2887882B1 (fr)	2007-09-07
CY1114989T1 (el)	2016-12-14
RS53211B (en)	2014-08-29
DOP2006000145A (es)	2008-01-31
CN101213196A (zh)	2008-07-02
BRPI0613020A2 (pt)	2010-12-14
PT1902054E (pt)	2009-04-22
JO2550B1 (en)	2010-09-05
TWI321566B (en)	2010-03-11
PT2020410E (pt)	2014-03-20
SI2020410T1 (sl)	2014-04-30

Legal Events

Date	Code	Title	Description
2016-01-22	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20150629

Publication	Publication Date	Title
HRP20150012T1 (xx)	2015-03-27	39-dezmetoksi derivati rapamicina
PL1802579T3 (pl)	2014-04-30	Pochodne 3-aryloaminopirydynowe
HUS2000022I1 (hu)	2020-07-28	Tiglien-3-on származékok
EP1878727A4 (en)	2013-11-13	2-AMINOQUINAZOLINE DERIVATIVES
IL185674A0 (en)	2008-01-06	1-benzylindole-2-carboxamide derivatives
IL192092A0 (en)	2008-12-29	Aryl-isoxazolo-4-yl-oxadiazole derivatives
HK1122797A1 (en)	2009-05-29	Derivatives of pyrido
ZA200802088B (en)	2008-11-26	4-Phenyl-6-substitued-pyrimidine-2-carbonitrile derivatives
ZA200802421B (en)	2009-01-28	1-Acyldihydropyrazol derivatives
ZA200804257B (en)	2009-04-29	Azaindole-2-carboxamide derivatives
EP1893625A4 (en)	2012-12-26	PROCESS FOR THE PREPARATION OF 9-DEAZAPURINE DERIVATIVES
ZA200805353B (en)	2009-10-28	Aryl-isoxazol-4-yl-imidazole derivatives
IL213474A0 (en)	2011-07-31	Processes for the preparation of cyclopropyl-amide derivatives
IL191138A0 (en)	2008-12-29	Pyrazoloisoquinoline derivatives
ZA200800348B (en)	2009-01-28	Derivatives of seleno-amino acids
HK1110079A1 (en)	2008-07-04	Imidazopyridine derivative
GB0511410D0 (en)	2005-07-13	Benzotrizepinone derivatives
TWI340746B (en)	2011-04-21	Naphthyridin derivatives
ZA200809112B (en)	2009-07-29	N-oxides of pyridylmethylpiperazine and -piperidine derivatives
ZA200706577B (en)	2010-02-24	Dihydroimidazothiazole derivatives
HU0500461D0 (en)	2005-07-28	Pyperazinyl derivatives of alkyl-oxindoles
PL381715A1 (pl)	2007-06-25	Nowe pochodne piperazynowe dialkilooksindoli
HUP0500463A3 (en)	2009-04-28	Pyridine derivatives of dialkyl-oxindoles
HU0500462D0 (en)	2005-07-28	Pyridinyl derivatives of alkyl-oxindoles
IL194758A0 (en)	2009-08-03	N-oxides of pyridylmethylpipertazine and-piperidine derivatives